refining biomarker testing and targeted treatment of nsclc with egfr mutations
Published 1 year ago • 967 plays • Length 59:37Download video MP4
Download video MP3
Similar videos
-
1:07:31
precision decisions in genomic testing and targeted treatment of nsclc
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
10:28
candid conversations in lung cancer: discussing biomarker testing and targeted therapies
-
1:39:03
everything you need to know about biomarker testing and treatment of genomically altered nsclc
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
45:57
refining precision decisions in nsclc with common and less common egfr mutations
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
1:11:32
refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
41:59
testing for common and uncommon egfr mutations to guide egfr-targeted therapy in nsclc
-
1:14:14
fine-tuning biomarker testing to identify and target ret fusions in nsclc
-
1:00:20
it’s precisely the time for more precision in genomic testing and targeted treatment of nsclc
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
1:04:49
everything you need to know about molecular testing and targeted therapies in nsclc
-
58:57
navigating the complexities of biomarker testing in the expanding field of precision immuno-oncology